XCUR Share Price Performance
US$2.99
-8.01 (-72.82%)
Price US$2.99
Share Pricen/a
Exicure, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
XCUR Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Exicure, Inc. Key Details
About XCUR
- Founded
- 2011
- Employees
- 8
- CEO
- WebsiteView website
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
